Apinocaltamide is under investigation in clinical trial NCT03239691 (A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.